Bone Metastases and Osteoporosis
|
|
- Horatio Benson
- 5 years ago
- Views:
Transcription
1 Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Bone Metastases and Osteoporosis
2 Bone Metastases Version 2002: Dall / Fersis / Friedrich Version : Bischoff / Böhme / Brunnert / Diel / Friedrichs / Maas / Oberhoff / Schaller / Seegenschmiedt / Solomayer / Souchon Version 2010: Solomayer / Schaller
3 Bisphosphonates in Breast Cancer Hypercalcemia 1a A ++ Reduction sceletal events (complications) 1a A ++ Treatment beyond progression of bone met s 5 D ++ Prevention of bone metastases Primary breast cancer 1b B +* Advanced breast cancer 2b C +/- Tumor Therapy-Induced Osteoporosis Prevention 1b B ++ Therapy 1b B ++ Prevention and Therapy of Tumor Therapy-Induced 1b B + Bone Loss * Study participation recommended
4 Skeletal Metastasis Treatment with Radionuclids Tumor progression after standard treatment of multiple / disseminated metastases and intolerable bone pain 1b B Rhenium-hydroxyethylidenediphosphonat (z.b. 186 Re-HEDP) 2b B Samarium 1b B + 89 Strontium (z.b. Sr 89 ) 1b B + Cave: Myelosuppression with risks of pancytopenia has to balance potential benefits.
5 Bone Metastases Acute Spinal Cord Compression / Paraplegia Decompression surgery, reduction of tumor volume, stabilisation surgery (< 24 h) and irradiation of the spine (RT) 2b C ++ Irradiation of the spine (< 24 h) +/- steroids 3b C ++ Immediate start of treatment 1c D ++ Clinical trials have included patients with different tumor entities!
6 Prognostic Factors Outcome of Spinal Cord Compression Oxford LoE: 2b GR: B Mobility before therapy Time interval from onset of neurological symptoms and start of therapy Rades et al, Prognostic factors predicting functional outcomes, recurrence-free Survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients. Int J Radiat Oncol Biol Phys 2006; 64:
7 Metastatic Bone Disease of the Spine Indications for surgery Oxford LoE: 2b GR: C AGO: ++ Spinal cord compression With progressive neurological symptoms With pathological fractures Instability of the spine Lesions in pre-irradiated parts of the spine
8 Surgery for Bone Metastases Spine and limbs Oxford LoE: 3b GR: C AGO: ++ Marrow splints Osteosynthesis Bone replacement by PMMA or titanspacer Endoprothesis Vertebroplasty / Kyphoplasty Resection of involved bone in oligometastatic disease (sternum, ribs, vertebral bodies)
9 Metastatic Bone Disease: Radiotherapy Bone metastases With fracture risk 1a B ++ With functional impairment 1a B ++ With bone pain 1a B ++ Single RT = fractionated RT 2a B ++ With neuropathic bone pain 1b B ++ Asymptomatic isolated bone metastases 5 D +/- Only few studies included breast cancer patients!
10 Metastatic Bone Disease Recurrent Bone Pain Recurrent bone pain in pre-irradiated parts of the skeleton Single RT (1 x 8 gy) 3b C ++ Fractionated RT (6 x 4 gy)! 3b C + Radionuclid therapy 3b C +
11 Prevention and Therapy of Tumor Therapy-Induced Bone Loss Regular BMD-measurement recommended 2b B + Bisphosphonates 1b B + RANK-ligand antibody 2b B + HRT (independent from ER-status of BC) 5 D - Some data derived from steroid induced bone loss*: Physical activity 4 C ++ Calcium and vitamine D suppl. 4 C ++ Avoiding BMI < 18 3b C ++ *Fischer M. Leitlinie für die Radionuklidtherapie bei schmerzhaften Knochenmetastasen. Nuklearmedizin 1999;38:
12 Prevention of Tumor Therapy-Induced Osteoporosis Regular BMD-measurement recommended 2b B + Bisphosphonates 1b B ++ HRT (independent from ER-status of BC) 5 D -
13 Therapy of Tumor Therapy-induced Osteoporosis Bisphosphonates 1b B ++ HRT (independent from ER-status of BC) 5 D - Some data derived from steroid induced bone loss*: Physical activity 4 C ++ Calcium and vitamine D suppl. 4 C ++ Avoiding BMI < 18 3b C ++ *Fischer M. Leitlinie für die Radionuklidtherapie bei schmerzhaften Knochenmetastasen. Nuklearmedizin 1999;38:
14 Bisphosphonates For Therapy of Bone Metastases Clodronate PO 1600 mg daily 2b B ++ Clodronate IV 1500 mg q3w / q4w 2b B ++ Pamidronate IV 90 mg q3w / q4w 2b B ++ Ibandronate IV 6 mg q3w / q4w 2b B ++ Ibandronate PO 50 mg daily 2b B ++ Zoledronate IV 4 mg q4w 2b B ++ Other doses or schedules, e.g. derived from studies of adjuvant therapy or therapy of osteoporosis 5 D - -
Bone Metastases. Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. AGO e. V. in der DGGG e.v. sowie in der DKG e.v.
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Bone Metastases Bone Metastases Version 2002: Dall / Fersis / Friedrich Versions 2003 2011: Bischoff / Böhme / Brunnert / Diel
More informationOsteooncology and Bone Health
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Osteooncology and Bone Health Osteooncology and Bone Health Versions 2002 2017: Bischoff / Böhme / Brunnert / Dall / Diel /
More informationWinston Tan MD FACP Associate Professor of Medicine Mayo Clinic Florida
Winston Tan MD FACP Associate Professor of Medicine Mayo Clinic Florida } none } To develop an understanding of the management of bone metastasis through a multidisciplinary approach } Enable the learner
More informationBone Metastases. Sukanda Denjanta, M.Sc., BCOP Pharmacy Department, Chiangrai Prachanukroh Hospital
Bone Metastases Sukanda Denjanta, M.Sc., BCOP Pharmacy Department, Chiangrai Prachanukroh Hospital 1 Outline Pathophysiology Signs & Symptoms Diagnosis Treatment Spinal Cord Compression 2 General Information
More informationBREAST CANCER AND BONE HEALTH
BREAST CANCER AND BONE HEALTH Rowena Ridout, MD, FRCPC Toronto Western Hospital Osteoporosis Program University Health Network / Mount Sinai Hospital rowena.ridout@uhn.ca None to declare Conflicts of Interest
More informationFREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS The following questions are representative of questions that patients and family members ask when they visit the Bone and Cancer Foundation website or contact the Foundation
More informationBone metastases of solid tumors Diagnosis and management by
Bone metastases of solid tumors Diagnosis and management by Dr/RASHA M Abd el Motagaly oncology consultant Nasser institute adult oncology unit 3/27/2010 1 Goals 1- Know the multitude of problem of bone
More informationRadiotherapy symptoms control in bone mets. Francesco Cellini GemelliART. Ernesto Maranzano,MD. Session 5: Symptoms management
Session 5: Symptoms management Radiotherapy symptoms control in bone mets Francesco Cellini GemelliART Ernesto Maranzano,MD Director of Oncology Department Chief of Radiation Oncology Centre S. Maria Hospital
More informationManaging Skeletal Metastases
School of Breast Oncology 2012 Managing Skeletal Metastases Cathy Van Poznak, MD Assistant Professor University of Michigan Comprehensive Cancer Center Saturday, November 3, 2012 Learning Objectives: Define
More informationBisphosphonates in the Management of. Myeloma Bone Disease
Bisphosphonates in the Management of Myeloma Bone Disease James R. Berenson, MD Medical & Scientific Director Institute for Myeloma & Bone Cancer Research Los Angeles, CA Myeloma Bone Disease Myeloma cells
More informationManaging Bone Pain in Metastatic Disease. Rachel Schacht PA-C Medical Oncology and Hematology Associates Presented on 11/2/2018
Managing Bone Pain in Metastatic Disease Rachel Schacht PA-C Medical Oncology and Hematology Associates Presented on 11/2/2018 None Disclosures Managing Bone Pain in Metastatic Disease This lecture will
More informationCNS Metastases in Breast Cancer
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer CNS Metastases in Breast Cancer CNS Metastases in Breast Cancer Version 2006: Maass / Junkermann Version 2007 2009: Bischoff
More informationIsotopes and Palliative Radiotherapy for bone metastases
Isotopes and Palliative Radiotherapy for bone metastases Rationale for Bone-seeking Isotope Therapies in Prostate Cancer > 90% of patients with advanced prostate cancer have bone metastases which can be
More informationThe Latest is the Greatest. Future Directions in the Management of Patients with Bone Metastases from Breast Cancer
City Wide Medical Oncology Rounds Friday Sept. 21 st, 2007 The Latest is the Greatest Future Directions in the Management of Patients with Bone Metastases from Breast Cancer Mark Clemons Head, Breast Medical
More informationCase Conference: SBRT for spinal metastases D A N I E L S I M P S O N M D 3 / 2 7 / 1 2
Case Conference: SBRT for spinal metastases D A N I E L S I M P S O N M D 3 / 2 7 / 1 2 Case 79 yo M with hx of T3N0 colon cancer diagnosed in 2008 metastatic liver disease s/p liver segmentectomy 2009
More informationIsotopes and Palliative Radiotherapy for bone metastases
Isotopes and Palliative Radiotherapy for bone metastases Rationale for Bone-seeking Isotope Therapies in Prostate Cancer > 90% of patients with advanced prostate cancer have bone metastases which can be
More informationSession 5: Isotope therapies and palliative radiotherapy
Session 5: Isotope therapies and palliative radiotherapy Jeffrey Tuan, FRCR Radiation Oncology National Cancer Centre Singapore 15 Dec 2016 Bone metastases SREs are clinically important endpoints The burden
More informationNEW ASPECTS OF RADIONUCLIDE THERAPY OF BONE AND JOINT DISEASES
NEW ASPECTS OF RADIONUCLIDE THERAPY OF BONE AND JOINT DISEASES M.FISCHER Department of Nuclear Medicine, Klinikum Kassel, Kassel, Germany XA0102662 Abstract. Whereas in developing countries P-32 is widely
More informationThe management and treatment options for secondary bone disease. Omi Parikh July 2013
The management and treatment options for secondary bone disease Omi Parikh July 2013 Learning Objectives: The assessment and diagnostic process of patients with suspected bone metastases e.g bone scan,
More informationCurrent Management of Metastatic Bone Disease
Current Management of Metastatic Bone Disease Evaluation and Medical Management Dr. Sara Rask Head, Medical Oncology Simcoe Muskoka Regional Cancer Centre www.rvh.on.ca Objectives 1. Outline an initial
More informationbone HEALTH IN FOCUS UNDERSTANDING THE IMPORTANCE OF BONE HEALTH WHEN LIVING WITH METASTATIC BREAST CANCER
bone HEALTH IN FOCUS UNDERSTANDING THE IMPORTANCE OF BONE HEALTH WHEN LIVING WITH METASTATIC BREAST CANCER IF YOU VE BEEN DIAGNOSED WITH METASTATIC BREAST CANCER (ALSO KNOWN AS STAGE IV BREAST CANCER),
More informationManagement of Acute Oncological emergencies
Management of Acute Oncological emergencies Malignant Spinal cord compression (MSCC) Neutropenic sepsis Superior vena caval obstruction Hypercalcemia Hyponatremia Bowel obstruction Brain Metastasis with
More informationManagement of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital
Management of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital Common problems in myeloma Myeloma-related complications/symptoms
More informationPrognostic and Predictive Factors
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Prognostic and Predictive Factors Prognostic and Predictive Factors Version 2002: Thomssen / Harbeck Version 2003 2009: Costa
More informationMetastatic Spinal Disease
Metastatic Spinal Disease Mr Neil Chiverton Consultant Spinal Surgeon, Sheffield Objectives The scale and nature of the problem NICE recommendations Surgical decision making Case illustrations Incidence
More informationBone Health in Patients with Multiple Myeloma
Bone Health in Patients with Multiple Myeloma Amrita Y. Krishnan, MD Director Judy and Bernard Briskin Myeloma Center City of Hope Comprehensive Cancer Center Bone Health Bisphosphonates in Space Bone
More informationBone Health in the Cancer Patient. Stavroula Otis, M.D. Primary Care and Oncology: Practical Lessons Conference Brea Community Center May 10, 2018
Bone Health in the Cancer Patient Stavroula Otis, M.D. Primary Care and Oncology: Practical Lessons Conference Brea Community Center May 10, 2018 Overview Healthy bone is in a constant state of remodelling
More informationClinical Case Conference
Clinical Case Conference Palliative radiation therapy for bone metastasis Jeff Burkeen, MD, PGY2 7/20/2015 1 Overview Epidemiology Pathophysiology Common presentations and symptoms Imaging Surgery Radiation
More informationMinimally Invasive Radiofrequency Ablation Treatment of Metastatic Spinal Tumors
Minimally Invasive Radiofrequency Ablation Treatment of Metastatic Spinal Tumors 1 Objectives Demographics of spinal tumors Treatment options and goals Adoption of RF ablation for pain palliation by NCCN
More informationInitial Pathway for DEXA Referral and Treatment for Fracture Risk Reduction in Postmenopausal Women and Men Age 50 or Above
Initial Pathway for DEXA Referral and Treatment for Fracture Risk Reduction in Postmenopausal Women and Men Age 50 or Above 2 or > vertebral fractures Low trauma fracture In past 5 years Risk Factors (table1)
More informationACR Appropriateness Criteria Spinal Bone Metastases EVIDENCE TABLE
1. Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group.
More informationElderly men with prostate cancer + ADT
Elderly men with prostate cancer + ADT Background and Rationale ADT and Osteoporosis Proportion of Patients With Fractures 1-5 Yrs After Cancer Diagnosis 21 18 +6.8%; P
More informationQuestions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss. A Publication of The Bone and Cancer Foundation
Questions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss A Publication of The Bone and Cancer Foundation Contents This publication includes important information about
More informationQuestions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss. A Publication of The Bone and Cancer Foundation
Questions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss A Publication of The Bone and Cancer Foundation Contents This publication includes important information about
More informationDuctal Carcinoma in Situ (DCIS)
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Ductal Carcinoma in Situ (DCIS) Ductal Carcinoma in Situ DCIS Versions 2002 2017: Audretsch / Blohmer / Brunnert / Budach /
More informationManagement of complications and side-effects of myeloma. Jackie Quinn Myeloma CNS Belfast Trust
Management of complications and side-effects of myeloma Jackie Quinn Myeloma CNS Belfast Trust Common problems in myeloma Myeloma-related complications/symptoms Treatment-related side-effects Myeloma bone
More informationSpinal cord compression as a first presentation of cancer: A case report
J Pain Manage 2013;6(4):319-322 ISSN: 1939-5914 Nova Science Publishers, Inc. Spinal cord compression as a first presentation of cancer: A case report Nicholas Lao, BMSc(C), Michael Poon, MD(C), Marko
More informationEndocrine Therapy of Metastatic Breast Cancer
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Endocrine Therapy of Metastatic Breast Cancer Endocrine Therapy of Metastatic Breast Cancer Version 2002: Gerber / Friedrichs
More informationVol. 19, Bulletin No. 108 August-September 2012 Also in the Bulletin: Denosumab 120mg for Bone Metastases
ה מ ר א פ הביטאון לענייני תרופות ISRAEL DRUG BULLETIN 19 years of unbiased and independent drug information P H A R x M A Vol. 19, Bulletin No. 108 August-September 2012 Also in the Bulletin: Denosumab
More informationa Phase II Randomised Controlled Trial Matthias Guckenberger
Dose-intensified Image-guided Fractionated Stereotactic Body Radiation Therapy for Painful Spinal Metastases (DOSIS) versus Conventional Radiation Therapy: a Phase II Randomised Controlled Matthias Guckenberger
More informationThe management and treatment options for secondary bone disease. Dr Jason Lester Clinical Oncologist Velindre Cancer Centre
The management and treatment options for secondary bone disease Dr Jason Lester Clinical Oncologist Velindre Cancer Centre Aims Overview of bone metastases management in castrate-refractory prostate cancer
More informationXgeva. Xgeva (denosumab) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.18 Subject: Xgeva Page: 1 of 5 Last Review Date: March 16, 2018 Xgeva Description Xgeva (denosumab)
More informationImaging of bone metastases
Imaging of bone metastases Antoine Feydy Service de Radiologie B Hôpital Cochin APHP Université Paris Descartes antoine.feydy@aphp.fr MEXICO 2016 INTRODUCTION Diagnostic Imaging Imaging Modalities Strengths,
More informationPalliative radiotherapy in lung cancer
New concepts and insights regarding the role of radiation therapy in metastatic disease Umberto Ricardi University of Turin Department of Oncology Radiation Oncology Palliative radiotherapy in lung cancer
More informationImpact of zoledronic acid on control of metastatic spinal cord compression
Strahlenther Onkol 2012 188:910 916 DOI 10.1007/s00066-012-0158-4 Received: 16 May 2012 Accepted: 30 May 2012 Published online: 18. August 2012 Springer-Verlag 2012 D. Rades 1 S.G. Hakim 2 A. Bajrovic
More informationBone targeted radionuclide therapy. Val Lewington Royal Marsden Hospital, London
Bone targeted radionuclide therapy Val Lewington Royal Marsden Hospital, London Bone malignancy Primary bone tumours Bone malignancy Primary bone tumours - chemotherapy, surgery & external beam radiotherapy
More information8/2/2018. Acknowlegements: TCP SPINE. Disclosures
A Presentation for the AAPM Annual meeting, Aug 2, 2018 Nashville, TN Stereotactic Radiosurgery for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards for Future
More informationKey words: Bisphosphonates, guidelines, drug use evaluation, breast cancer
DO PHYSICIA FOLLOW SYSTEMIC TREATMENT AND FUNDING POLICY GUIDELINES? A REVIEW OF BISPHOSPHONATE USE IN PATIENTS WITH BONE METASTASES FROM BREAST CANCER Mark Clemons 1, Katherine Enright 1, Annemarie Cesta
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other PROLIA, XGEVA 37012 If the caller wishes to initiate a request then a MRF must be completed. This drug requires a written request for prior authorization. All requests
More informationManagement of metastatic bone disease
Oncology 33 Management of metastatic bone disease Metastatic bone disease is a common cause of pain and disability for patients with advanced cancer. Early detection and appropriate management can limit
More informationRadiation Treatment for Breast. Cancer. Melissa James Radiation Oncologist August 2015
Radiation Treatment for Breast Cancer Melissa James Radiation Oncologist August 2015 OUTLINE External Beam Radiation treatment. (What is Radiation, doctor?) Role of radiation. (Why am I getting radiation,
More informationPalliative RT. Jiraporn Setakornnukul, M.D. Radiation Oncology Division Siriraj Hospital, Mahidol University
Palliative RT Jiraporn Setakornnukul, M.D. Radiation Oncology Division Siriraj Hospital, Mahidol University Scope Brain metastasis Metastasis epidural spinal cord compression SVC obstruction Bone pain
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Proposed Health Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Proposed Health Technology Appraisal Radium-223 chloride for the treatment of bone metastases in castrate resistant prostate cancer Draft scope Draft
More informationDumfries and Galloway. Treatment Protocol for Osteoporosis
Dumfries and Galloway Treatment Protocol for Osteoporosis DIAGNOSIS OF OSTEOPOROSIS 2 Diagnostic Criteria 2 Multiple low trauma vertebral fractures in the absence of myeloma or metastatic disease. 2 T-score
More informationOverview. Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases. People Centred Positive Compassion Excellence
Overview Osteoporosis and Metabolic Bone Disease Dr Chandini Rao Consultant Rheumatologist Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases Bone Biology Osteoporosis Increased bone remodelling
More informationPALLIATIVE RADIOTHERAPY FOR BONE METASTASES: AN ASTRO EVIDENCE-BASED GUIDELINE
Int. J. Radiation Oncology Biol. Phys., Vol. 79, No. 4, pp. 965 976, 2011 Copyright Ó 2011 American Society for Radiation Oncology and American College of Radiology Printed in the USA. All rights reserved
More informationRecognition & Treatment of Malignant Spinal Cord Compression Study Day
Recognition & Treatment of Malignant Spinal Cord Compression Study Day 11 th May 2017 Dr Bernie Foran Consultant Clinical Oncologist & Honorary Senior Lecturer Weston Park Hospital Outline of Talk Clinical
More informationTherapy Side Effects
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Therapy Side Effects Therapy Side Effects Versions 2004 2011: Albert / Bischoff / Costa / Friedrichs / Göhring / Jackisch/
More informationBeyond the Break. After Breast Cancer: Osteoporosis in Survivorship. Dr Alexandra Ginty CCFP(EM) FCFP Regional Primary Care Lead CCO
Beyond the Break After Breast Cancer: Osteoporosis in Survivorship Dr Alexandra Ginty CCFP(EM) FCFP Regional Primary Care Lead CCO Disclosures No disclosures Osteoporosis in Breast Cancer Survivorship
More informationCommunity care of Prostate Cancer. Shaun Costello Southern Cancer Network
Community care of Prostate Cancer Shaun Costello Southern Cancer Network Introduction Why is GP follow up of prostate cancer important 4Years In Waikato Faster Cancer Treatment Reporting against the 3
More informationGuideline for the investigation and management of osteoporosis. for hospitals and General Practice
Guideline for the investigation and management of osteoporosis for hospitals and General Practice Background Low bone density is an important risk factor for fracture. The aim of assessing bone density
More informationWhat Lung Cancer Patients Need to Know About Bone Health. A Publication of The Bone and Cancer Foundation
What Lung Cancer Patients Need to Know About Bone Health A Publication of The Bone and Cancer Foundation Contents THIS PUBLICATION PROVIDES IMPORTANT INFORMATION ABOUT THE RELATIONSHIP BETWEEN LUNG CANCER
More informationThe use of surgery in the elderly. for management of metastatic epidural spinal cord compression
The use of surgery in the elderly Bone Tumor Simulators for management of metastatic epidural spinal cord compression Justin E. Bird, M.D. Assistant Professor Orthopaedic Oncology and Spine Surgery Epidemiology
More informationGLOSSARY. This glossary includes definitions for patients who have cancer with bone involvement. New definitions will be added periodically.
GLOSSARY This glossary includes definitions for patients who have cancer with bone involvement. New definitions will be added periodically. For more in-depth information, please refer to the Bone and Cancer
More informationAdjuvant bisphosphonates: our recommendations
Adjuvant bisphosphonates: our recommendations Andreas Makris Mount Vernon Cancer Centre OPTIMA launch meeting, 27 April 2017 Breast Cancer Metastasis Tumour cell colonisation of bone Tumour cell proliferation
More informationNATIONAL COALITION FOR OSTEOPOROSIS AND RELATED BONE DISEASES
NATIONAL COALITION FOR OSTEOPOROSIS AND RELATED BONE DISEASES Fact Sheet FY 2007 What is the Mission of the Bone Coalition? The National Coalition for Osteoporosis and Related Bone Diseases is dedicated
More informationPalliative treatments for lung cancer: What can the oncologist do?
Palliative treatments for lung cancer: What can the oncologist do? Neil Bayman Consultant Clinical Oncologist GM Cancer Palliative Care and Lung Cancer Education Event Manchester, 31 st January 2017 Most
More informationACR Appropriateness Criteria Metastatic Epidural Spinal Cord Compression and Recurrent Spinal Metastasis EVIDENCE TABLE
. Cole JS, Patchell RA. Metastatic epidural spinal cord compression. Lancet Neurol. 2008;7(5):59-66. 2. Loblaw DA, Mitera G, Ford M, Laperriere NJ. A 20 updated systematic review and clinical practice
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice Review consultation document Review of Clinical Guideline (CG75) Metastatic spinal cord compression: diagnosis and management
More informationHot Topics in Bone Disease in 2017: Building Better Bones Breaking News in Osteoporosis
Hot Topics in Bone Disease in 2017: Building Better Bones Breaking News in Osteoporosis Aromatase Inhibitor-Induced Bone Loss in Early Breast Cancer Rachel Pessah-Pollack, M.D., F.A.C.E. Mount Sinai School
More informationPalliative Medicine Doctors Meeting
Updates on the Disease Management of Bone Metastases Dr. Carmen LEUNG Department of Clinical Oncology, Queen Elizabeth Hospital Correspondence: lwlc01@ha.org.hk ABSTRACT: Bone metastases are a frequent
More informationMetastatic Disease of the Proximal Femur
CASE REPORT Metastatic Disease of the Proximal Femur WI Faisham, M.Med{Ortho)*, W Zulmi, M.S{Ortho)*, B M Biswal, MBBS** 'Department of Orthopaedic, "Department of Oncology and Radiotherapy, School of
More informationManaging Skeletal Metastases
Managing Skeletal Metastases Alison Stopeck, M.D. Professor of Medicine Director, Breast Cancer Program University of Arizona Cancer Center Tucson, AZ Disclosures: Consulting, research funding, and honoraria
More informationRadiotherapy for Patients with Symptomatic Intramedullary Spinal Cord Metastasis
J. Radiat. Res., 52, 641 645 (2011) Regular Paper Radiotherapy for Patients with Symptomatic Intramedullary Spinal Cord Metastasis Haruko HASHII 1,4 *, Masashi MIZUMOTO 1,4 *, Ayae KANEMOTO 1,4, Hideyuki
More informationRipamonti C, et al. ASCO 2012 (Abstract 9005)
ZOOM: A Prospective, Randomized Trial of Zoledronic Acid for Long-term Treatment in Patients With Bone-Metastatic Breast Cancer After 1 Year of Standard Zoledronic Acid Treatment D. Amadori, M. Aglietta,
More informationRadiopharmaceuticals for treating CRPC patients with metastatic bone disease 2014/6/27
Radiopharmaceuticals for treating CRPC patients with metastatic bone disease 和信醫院黃玉儀 2014/6/27 Bone metastases in prostate cancer The most common site of metastasis in prostate cancer In >90% patients
More informationQuando e qual o momento de iniciar os Bifosfonatos no Câncer de Próstata
Quando e qual o momento de iniciar os Bifosfonatos no Câncer de Próstata Igor A. Protzner Morbeck, MD, MSc Professor de Medicina Universidade Católica de Brasília Oncologista Clínico Onco-Vida Brasília-DF
More information4.7 Studies of Quality Holy Cross Hospital Bone Health Early Stage I ER/PR Positive Breast Cancer Patients December 13, 2017
4.7 Studies of Quality Holy Cross Hospital 2017 Bone Health Early Stage I ER/PR Positive Breast Cancer Patients December 13, 2017 Bone Health in Stage I ER/PR Positive Breast Cancer Patients To review
More informationAdvanced Prostate Cancer. November Jose W. Avitia, M.D
Advanced Prostate Cancer November 4 2017 Jose W. Avitia, M.D In 2017 161,000 new cases of prostate cancer diagnosed in US, mostly with elevated PSA 5-10% will present with metastatic disease In 2017: 26,000
More informationXgeva. Xgeva (denosumab) Description. Section: Prescription Drugs Effective Date: January 1, 2016
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.07.18 Subject: Xgeva Page: 1 of 5 Last Review Date: December 3, 2015 Xgeva Description Xgeva (denosumab)
More informationProstate Case Scenario 1
Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has
More informationDENOSUMAB (PROLIA & XGEVA )
DENOSUMAB (PROLIA & XGEVA ) UnitedHealthcare Oxford Clinical Policy Policy Number: PHARMACY 306.3 T2 Effective Date: July 2, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 CONDITIONS OF COVERAGE...
More informationBreast Cancer and Bone Loss. One in seven women will develop breast cancer during a lifetime
Breast Cancer and Bone Loss One in seven women will develop breast cancer during a lifetime Causes of Bone Loss in Breast Cancer Patients Aromatase inhibitors Bil Oophorectomy Hypogonadism Steroids Chemotherapy
More informationDisclosures. Overview 8/3/2016. SRS: Cranial and Spine
SRS: Cranial and Spine Brian Winey, Ph.D. Department of Radiation Oncology Massachusetts General Hospital Harvard Medical School Disclosures Travel and research funds from Elekta Travel funds from IBA
More informationPalliative treatment of bone metastases with samarium-153
APPROVED BY: Z. Yang Page 1 of 5 Palliative treatment of bone metastases with samarium-153 Primary Indications: Rationale: To treat bone pain resulting from osteoblastic metastases as defined by bone scan.
More information20. Background. Oligometastases. Oligometastases: bone (including spine) and lymph nodes
125 20. Oligometastases Background The oligometastatic state can be defined as 1 3 isolated metastatic sites, typically occurring more than six months after successful treatment of primary disease. 1 In
More informationOsteoporosis Update. Greg Summers Consultant Rheumatologist
Osteoporosis Update Greg Summers Consultant Rheumatologist DEFINITION OSTEOPOROSIS is LOW BONE MASS (& micro-architectural deterioration) causing AN INCREASED RISK OF FRACTURE 23 years 82 years 23 y/o
More informationDental Issues In Cancer Patients Using Bone Modifying Agents What Every GPO Must Know
Dental Issues In Cancer Patients Using Bone Modifying Agents What Every GPO Must Know Dr. Allan Hovan, DMD, MSD, FRCD (C) 2016 CAGPO Annual Meeting Four Seasons Hotel, Vancouver, B.C. Sunday, October 2
More informationIncorporating New Agents into the Treatment Paradigm for Prostate Cancer
Incorporating New Agents into the Treatment Paradigm for Prostate Cancer Dr. Celestia S. Higano FACP, Professor, Medicine and Urology, Uni. of Washington Member, Fred Hutchinson Cancer Research Center
More informationOutline. Vertebroplasty and Kyphoplasty. Epidemiology. Identifying Vertebral Fractures. Page 1
Outline Vertebroplasty and Kyphoplasty Douglas C. Bauer, MD University of California San Francisco, USA Vertebral fracture epidemiology, consequences and diagnosis Kyphoplasty and vertebroplasty: what
More informationAdjuvant Endocrine Therapy in Pre- and Postmenopausal Patients
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Adjuvant Endocrine Therapy in Pre- and Postmenopausal Patients Adjuvant Endocrine Therapy in Pre- and Postmenopausal Patients
More informationJMSCR Vol 06 Issue 12 Page December 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.15 Single Institutional Comparative
More informationOsteoporosis Clinical Guideline. Rheumatology January 2017
Osteoporosis Clinical Guideline Rheumatology January 2017 Introduction Osteoporosis is a condition of low bone mass leading to an increased risk of low trauma fractures. The prevalence of osteoporosis
More informationThis talk will cover. Myeloma kidney disease, pain and fatigue: complications of myeloma and side-effects of treatment. Pain.
This talk will cover Myeloma kidney disease, pain and fatigue: complications of myeloma and side-effects of treatment Shirley Crofts Myeloma Clinical Nurse Specialist University Hospital Southampton NHS
More informationChallenges in the management of metastatic prostate cancer
Oncology 323 Challenges in the management of metastatic prostate cancer A significant number of men with prostate cancer will be elderly. Although some of the issues they face will be the same as their
More information[If no, skip to question 10.] Y N. 2. Does the member have a diagnosis of Paget s disease of bone? Y N. [If no, skip to question 4.
Pharmacy Prior Authorization AETA BETTER HEALTH EW JERSE (MEDICAID) Zoledronic Acid (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,
More information3. Has bone specific alkaline phosphatase level increased OR does the member have symptoms related to active Paget s?
Pharmacy Prior Authorization AETA BETTER HEALTH VIRGIIA CCC PLUS and MEDALLIO/FAMIS 4.0 Zoledronic Acid (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review
More informationOptimal Management of Isolated HER2+ve Brain Metastases
Optimal Management of Isolated HER2+ve Brain Metastases Eliot Sims November 2013 Background Her2+ve patients 15% of all breast cancer Even with adjuvant trastuzumab 10-15% relapse Trastuzumab does not
More informationBreast Cancer and Bone Health. Robert Coleman, Cancer Research Centre, Weston Park Hospital, Sheffield
Breast Cancer and Bone Health Robert Coleman, Cancer Research Centre, Weston Park Hospital, Sheffield Breast Cancer and Bone Health Normal Bone Health Impact of Cancer Therapies on Bone Health Therapeutic
More informationDownload slides:
Download slides: https://www.tinyurl.com/m67zcnn https://tinyurl.com/kazchbn OSTEOPOROSIS REVIEW AND UPDATE Boca Raton Regional Hospital Internal Medicine Conference 2017 Benjamin Wang, M.D., FRCPC Division
More information